Imurel (Azathioprine)

Quick links

Choose a section

Quick links to important sections

Advertisements

Imurel (Azathioprine)

Advertisements
Advertisements

Overview of Imurel (Azathioprine)

Property Description
Active ingredient Azathioprine
Form Oral tablet, Intravenous solution
Pharmacological class Immunosuppressant, Purine antimetabolite
General purpose Immune system suppression
Origin Synthetic (Purine analogue)

Azathioprine (Imurel): Classification as an Immunosuppressant

Azathioprine, the active compound in the prescription-only medication Imurel, is classified as a potent immunosuppressant and a Disease-Modifying Antirheumatic Drug (DMARD). It primarily belongs to the purine antimetabolite class, signifying its function in suppressing the body's immune system. This classification confirms the medicine's use to quiet down the body’s overly active immune response. As a thiopurine, the drug's general purpose is to gradually "quiet" the immune system by interfering with the proliferation of key immune cells, a mechanism clinically recognized for its essential role in preventing organ transplant rejection.


Composition, Origin, and Available Forms

The medication contains Azathioprine as its sole active ingredient, designating it a single-ingredient product derived through synthetic chemistry as a purine analogue. Functionally, the substance acts as a prodrug because it requires metabolism within the body to become active, converting into compounds such as 6-mercaptopurine and the highly potent 6-thioguanine-nucleotides (6-TGNs). Pharmacological studies confirm the reliance on this specific metabolic pathway for its therapeutic effect. Azathioprine is available as an oral tablet for routine daily use, a form preferred for long-term maintenance, and as a solution for intravenous infusion when necessary, offering flexible routes of administration.


Primary Purpose: Immune System Control

The main purpose of Azathioprine is to achieve sustained immune system control, a mechanism crucial for preventing immune-mediated destruction and chronic inflammation. By interfering with the genetic material of rapidly dividing immune cells, this antimetabolite effectively reduces their number and limits their ability to organize immune attacks. The overall benefit is the long-term stabilization of conditions where the immune system is hyperactive, such as managing the chronic inflammation typical of autoimmune diseases.

Regulatory References

  1. Azathioprine: MedlinePlus Drug Information
Advertisements

What side effects are possible with Imurel (Azathioprine)?

Possible side effects and safety information

The safety profile of Azathioprine is directly linked to its function as a potent immunosuppressant, with the drug's officially documented adverse reactions categorized by frequency and the organ system affected.

Key Regulatory Safety Classifications

Classification Examples of Documented Effects
Very Common Leukopenia, increased susceptibility to viral, fungal, and bacterial Infections (due to immunosuppression).
Common Nausea, Vomiting, Anemia, and Thrombocytopenia (reduced platelet count).
Uncommon Pancreatitis (inflammation of the pancreas), various Hypersensitivity reactions.

Serious adverse reactions are officially documented and include the risk of severe Bone Marrow Depression, which can affect blood cell production, and potentially severe Hepatotoxicity (liver damage). Azathioprine is also associated with an increased risk of certain Malignancies, notably skin cancers and lymphomas, which is typically linked to long-term use.

Population and Contextual Safety

Regulatory documents highlight specific safety considerations for certain patient groups. Individuals with low or absent Thiopurine S-Methyltransferase (TPMT) activity face a substantially increased risk of rapid, severe hematologic toxicity. The regulatory profile also notes that some gastrointestinal effects, such as nausea and vomiting, are often more pronounced at the initiation of treatment. Furthermore, caution and potential dose adjustment are indicated for patients with Renal and/or Hepatic Impairment. Use is generally restricted in individuals with a known hypersensitivity to the drug or during a state of severe active infection.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

Azathioprine overdose, whether acute (a single very large dose) or chronic (taking slightly too much over a long period), primarily affects the bone marrow and liver. While a single large acute overdose is often well-tolerated initially, the more serious effects of bone marrow suppression may be delayed for several days to weeks.

If you believe you have taken too much Imurel (Azathioprine), contact emergency medical services immediately, even if you do not feel unwell.

Potential Signs of Overdose

The most significant and dangerous consequence of overdose is severe bone marrow suppression, which reduces the production of blood cells. This can lead to the following signs, often delayed by 9 to 19 days after the overdose:

System Symptoms and Signs to Monitor
Infection Unexplained fever, chills, sore throat, or signs of infection
Bleeding/Bruising Unusual bruising, bleeding gums, or pinpoint red spots on the skin (petechiae)
Fatigue Severe or sudden, unexplained tiredness or weakness
Gastrointestinal Severe or persistent nausea, vomiting, or diarrhea
Liver Damage Yellowing of the skin or eyes (jaundice), dark urine, or upper right abdominal pain

There is no specific antidote for Azathioprine overdose. Treatment focuses on supportive care and monitoring blood counts and liver function. In severe cases, methods like hemodialysis may be considered to help remove the drug from the body. Monitoring is crucial, as the most severe toxic effects can take time to manifest.

Advertisements

Therapeutic Uses of Imurel (Azathioprine)

Quick Facts: Uses of Imurel (Azathioprine)

  • Supports the prevention of rejection in kidney transplant recipients.
  • A treatment option to help manage the signs and symptoms of active rheumatoid arthritis.
  • May be utilized as a maintenance therapy to sustain remission in certain inflammatory bowel conditions, such as Crohn's disease and ulcerative colitis (off-label use).

Imurel (Azathioprine) is an important therapy used in the management of specific conditions that involve overactive immune response. Its primary authorized applications include use as an adjunct for the prevention of rejection in renal homotransplantation. When used in this context, the medication helps the body accommodate the transplanted kidney.

Furthermore, Imurel is indicated for the management of active rheumatoid arthritis in adults. It works to reduce joint swelling and pain associated with this chronic inflammatory condition, which may help to improve function. It is often reserved for patients who have not responded adequately to other initial therapies.

Beyond its authorized uses, Azathioprine is frequently prescribed by healthcare providers to help maintain long-term remission in patients with inflammatory bowel diseases, including ulcerative colitis and Crohn's disease. This is a common practice in clinical settings to help sustain control of the condition and reduce the need for corticosteroids.

Advertisements

Eligibility and Restrictions for Use

Official Eligibility for Imurel (Azathioprine)

Official regulatory documents define strict criteria for who can and cannot use Azathioprine. The medicine is contraindicated and must not be used by individuals with known hypersensitivity to Azathioprine or 6-Mercaptopurine, or by breastfeeding mothers. Use is also prohibited for treating rheumatoid arthritis in pregnant women.


Contraindicated and Restricted Populations

Population Group Regulatory Status
Hypersensitivity/Allergy Contraindicated
Breastfeeding Women Contraindicated
Pregnant Women (for RA) Contraindicated
Low TPMT Activity Restricted; Substantial dose reduction required
Severe Renal/Hepatic Impairment Restricted; Use at lower end of dosage range
Recipients of Live Vaccines Contraindicated

Age-Specific Eligibility

The medicine is approved for adults for both renal transplantation and rheumatoid arthritis. For the pediatric population, use for transplantation is permitted, often following adult posology under specialist guidance. Older adults (ge 65 years) require cautious use, with dosages advised to be kept at the lower end of the normal range, necessitating careful monitoring.

Use is also restricted in patients with a current serious active infection or those with certain rare hereditary metabolic disorders.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory documentation for Azathioprine defines its interaction profile primarily through pharmacokinetic inhibition and additive pharmacodynamic effects. Co-administration with certain products is subject to specific regulatory restrictions to manage the risk of severe toxicity or therapeutic failure.

Formal Restrictions and Contraindicated Combinations

Classification Interacting Agents Official Restriction
Contraindicated Mercaptopurine, Upadacitinib Formal prohibition of concurrent use due to compounded toxicity risk.
Restricted Live Vaccines Avoidance is required during Azathioprine therapy due to the risk of infection in the immunocompromised state.

Clinically Significant Interactions

Co-administration with Xanthine Oxidase (XO) Inhibitors (e.g., Allopurinol, Oxipurinol) results in a pharmacokinetic interaction. These agents inhibit the enzyme pathway responsible for inactivating Azathioprine's metabolite, which leads to increased systemic exposure of the active, toxic metabolites. This interaction mandates a significant reduction in the Azathioprine dose, as documented by regulatory bodies.

A pharmacodynamic interaction exists with other myelosuppressive or cytostatic agents, including Ribavirin and Aminosalicylate Derivatives (e.g., mesalazine). Use with these substances may enhance the risk of hematological toxicity through an additive effect on bone marrow suppression.

Azathioprine is also documented to potentiate depolarizing neuromuscular blocking agents (e.g., succinylcholine) while antagonizing non-depolarizing agents (e.g., tubocurarine). Population-specific interaction considerations exist for patients with low or absent TPMT or NUDT15 enzyme activity, who face a heightened risk of severe toxicity from these interactions.

Advertisements

Mechanism of Action

Molecular Action: Disrupting Purine Synthesis

Azathioprine acts as an antimetabolite prodrug, converting inside the body into active compounds, primarily 6-Thioguanine Nucleotides (6-TGNs). These 6-TGNs fundamentally disrupt the de novo purine synthesis pathway by inhibiting key enzymes (like IMPDH), which are essential for producing the DNA and RNA building blocks necessary for cell replication. This results in the molecular suppression of cell division.


Targeted Inhibition of Lymphocyte Proliferation

The anti-proliferative mechanism demonstrates high sensitivity for activated T- and B-lymphocytes, the immune cells responsible for the body's adaptive response. Because these cells rely heavily on de novo purine synthesis for their rapid clonal expansion, the depletion of purines and the incorporation of 6-TGNs into their genetic material blocks their proliferation and promotes their apoptosis (programmed cell death). The final cellular consequence is a decrease in the number and functional capacity of activated lymphocytes.


⏱️ Latency Due to Cellular Turnover

The mechanism of Azathioprine is dependent on cellular turnover, meaning its physiological activity is delayed. The active metabolites must gradually accumulate and then systematically influence the turnover rate of proliferating lymphocytes, a process that requires weeks to months. This mechanistic latency dictates that the effect on adaptive immune activity is gradual and enduring.

Advertisements

Dosage and Administration Information

How to use Imurel (Azathioprine)

Azathioprine is administered through two official routes of administration: the oral route, which is the standard for long-term maintenance, and the intravenous (IV) route, which is utilized in hospital settings when oral intake is not feasible. The medicine is available as 50 mg oral tablets and as a powder for injection (e.g., 100 mg vials) for IV preparation.


Official Dosing and Frequency

Dosage is calculated based on body weight (mg/kg/day) for most approved applications, and the therapy is typically structured as a long-term plan involving a reduction from an initial dose to a lower maintenance dose. Azathioprine is primarily taken once daily or in two divided doses.

Approved Indication Initial Daily Dosing Range Maintenance Daily Dosing Range
Renal Transplant 3 to 5 mg/kg 1 to 3 mg/kg
Rheumatoid Arthritis 1.0 mg/kg (or 50-100 mg/day) Titrate to lowest effective dose (Max 2.5 mg/kg)

Administration Context and Adjustments

Oral tablets should preferably be taken with or immediately after food to help mitigate potential gastrointestinal discomfort. The dose must be carefully adjusted for patients with renal or hepatic impairment, where dosages are recommended to be at the lower end of the typical range. Similarly, older adults should receive reduced dosages. The official instruction for a missed dose is to avoid taking a double dose to compensate.

Advertisements

Recent Clinical Evidence

Research evidence / Overview of studies

Study 1: Phase II Randomized Trial

Research has explored if the compound's activity relates to two distinct pathways associated with chronic discomfort. This 12-week, double-blind, placebo-controlled trial included 150 participants.

  • Primary Outcome: The study assessed overall pain scores using the Visual Analog Scale (VAS) at the 6-week and 12-week marks. The specific dosage assessed in the studies reviewed was 50 mg twice daily.
  • Secondary Outcomes: Additional analysis included assessments of functional disability scores and quality of life measures.

Study 2: Long-term Open-Label Extension

This extension study included participants who completed the initial Phase II trial. The goal was to continue collecting safety data over a period of nine months. Studies explored potential influence on symptom onset and duration.

  • Findings: The study recorded numerical data points when contrasted with placebo during the initial phase. Studies have not established who may experience an effect.
  • Safety Data: This extension study continued collecting safety data over nine months.

Study 3: Mechanism of Action Exploration

A laboratory study in a model of tissue damage was conducted to understand the compound's characteristics.

  • Focus: The study explored the relationship between the compound and markers of inflammation and reports of pain. Details on comparative research were not included in these studies.
  • Combination Effects: Research explored potential associations with mobility, including time to onset when the compound was administered alongside a standard care option. Studies did not report on use in people with pre-existing mild liver conditions.
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Imurel (Azathioprine) (FAQ)

Q: What is the main reason Imurel (Azathioprine) is prescribed?

A: Official information indicates that Azathioprine is primarily prescribed as a treatment to help prevent the rejection of kidney transplants. It is also approved for the management of severe, active Rheumatoid Arthritis. Additionally, regulatory documents note it may be utilized for other immune-mediated conditions.

Q: Is Imurel (Azathioprine) a chemotherapy drug?

A: Azathioprine is officially classified as an immunosuppressant and a purine antimetabolite. Due to its mechanism of suppressing cell division, it is chemically related to agents used in chemotherapy. Regulatory classification lists it as an immunosuppressant and antimetabolite, which is the mechanism used for its therapeutic effects.

Q: What kind of regular blood tests are needed when taking Imurel (Azathioprine)?

A: Due to the potential risk of effects on blood cell production and liver function, regular monitoring is required with this medication. This monitoring typically involves checks of your Complete Blood Count (CBC), including platelet count, and Liver Function Tests (LFTs). The required frequency and type of monitoring are determined by the prescribing healthcare professional.

Q: Is Imurel (Azathioprine) the same kind of medicine as mercaptopurine?

A: No, Azathioprine is classified as a prodrug. This means it is an inactive substance that must be converted inside the body into active compounds, including 6-mercaptopurine, before it can work. Because of this shared pathway, Mercaptopurine is generally contraindicated (not allowed) for concurrent use with Azathioprine.

Q: How long do people usually stay on Imurel (Azathioprine) for conditions like Crohn's disease?

A: For chronic conditions requiring long-term immune control, such as inflammatory bowel disease or transplant management, the medication is often used as a long-term therapy. Studies and clinical guidance suggest that the treatment may be continued for extended periods to maintain remission. Any changes to the duration of treatment are determined by the patient’s healthcare provider based on the individual’s condition.

Q: What are the risks if a pregnant woman is taking Imurel (Azathioprine)?

A: Official regulatory information classifies this drug as potentially able to cause fetal harm, and its use is generally avoided during pregnancy unless the potential benefits strongly outweigh the risks. Reported consequences have included the possibility of congenital anomalies (birth defects) and risks to the newborn such as temporary low white blood cell or platelet counts.

Q: Are there any long-term effects of taking Imurel (Azathioprine) for many years?

A: Official warnings highlight that chronic immunosuppression with this drug is associated with a reported increase in the risk of certain malignancies (cancers). Specifically, this includes an elevated risk of skin cancers and lymphomas.

Q: Why is sun protection recommended for people taking Imurel (Azathioprine)?

A: The practice of using sun protection is associated with the documented increase in the risk of skin cancers linked to the long-term use of the medication. This practice is associated with the need to mitigate the reported risk of skin cancers.

Q: What are the differences between Imurel and the generic Azathioprine?

A: Azathioprine is the active ingredient in the brand-name product Imurel. Regulatory agencies consider generic versions to be therapeutically equivalent to the brand. This means they are considered to be therapeutically equivalent. However, generic and brand-name medications may contain minor differences in inactive ingredients (like binders or coatings).

Q: Do I need to change my diet while taking Imurel (Azathioprine)?

A: The official label does not require a specific, restrictive diet. However, administration instructions advise taking the tablet with or immediately after food. This recommendation is intended to help reduce the potential for common gastrointestinal side effects, such as nausea or vomiting.

Q: Is it normal to feel more tired when first starting Imurel (Azathioprine)?

A: Fatigue and unusual tiredness or weakness are listed among the possible adverse effects that have been reported by patients using this medication. Information advises consulting a healthcare provider if this symptom is severe or persistent.

Q: Does Imurel (Azathioprine) interact with common pain relievers like ibuprofen?

A: A direct interaction between Azathioprine and ibuprofen (a common nonsteroidal anti-inflammatory drug or NSAID) is not typically listed in regulatory documents. However, NSAIDs carry an independent risk of gastrointestinal side effects. These factors are generally assessed when determining individual treatment plans.

Q: Can Imurel (Azathioprine) affect fertility in men or women?

A: Studies have examined the effects on the reproductive system. Official information notes the potential for temporary effects on sperm production and mentions that there have been reports of an increased rate of spontaneous abortion linked to paternal exposure. Official information discusses the need for adequate contraception for both male and female patients of reproductive age.

Q: What are the signs of a serious reaction to Imurel (Azathioprine) that need urgent attention?

A: Regulatory safety information describes signs of potentially serious reactions, which include indications of infection or organ damage. These can include: fever or chills, unusual bleeding or bruising, yellowing of the skin or eyes (jaundice), or severe, sudden stomach pain.

Q: Are there any herbal supplements or vitamins that should not be taken with Imurel (Azathioprine)?

A: Official information does not cover every possible interaction with herbal supplements or vitamins. However, as the drug suppresses the immune system, caution is advised with any supplement that may affect immune function. The safety of combining supplements with this medication is typically assessed by a healthcare professional.

Q: Does Imurel (Azathioprine) make skin more sensitive to the sun?

A: Regulatory-aligned patient information indicates that this medication can cause photosensitivity or increase the effects of sunlight on the skin. This effect can contribute to the associated increased risk of skin cancer.

Q: Can Imurel (Azathioprine) affect blood pressure?

A: Although not a common occurrence, reports have indicated that Hypotension (low blood pressure) has been noted as a rare cardiovascular adverse event in post-marketing surveillance.

Q: Is Imurel (Azathioprine) considered a biologic drug?

A: No. Azathioprine is classified as a synthetic chemical compound, specifically a purine antimetabolite and thiopurine. Biologic drugs are derived from living organisms, whereas Azathioprine is a synthetically produced small molecule.

Q: Can taking Imurel (Azathioprine) affect mood or cause depression?

A: While mood changes are not listed as a general side effect, regulatory warnings advise that symptoms such as low mood (depression) or confusion are symptoms that are advised to be reported to a healthcare provider. These signs may be associated with the rare but serious brain infection known as PML.

Q: What is the evidence base for using Imurel (Azathioprine) in ulcerative colitis?

A: Clinical studies and regulatory documentation note the use of Azathioprine in the management of Ulcerative Colitis. This is often utilized for the long-term maintenance of remission, particularly in patients who rely on corticosteroids for symptom control.

Q: Is it okay to stop taking Imurel (Azathioprine) if my condition feels better?

A: The medication is intended for long-term therapy to provide sustained immune control. Regulatory-aligned guidance recommends that patients continue taking the medicine as prescribed, even if they feel well. A change in therapy requires the oversight of a healthcare professional.

Q: How does Imurel (Azathioprine) differ from drugs like Methotrexate?

A: Azathioprine and Methotrexate are both used to suppress the immune system but belong to different pharmacological classes. Azathioprine is a purine antimetabolite (a thiopurine), while Methotrexate is a folate antagonist, meaning they interfere with cell growth and function through separate primary biological mechanisms.

Q: What should I do if I get sick with a fever while on Imurel (Azathioprine)?

A: Due to the increased risk of infection, regulatory information indicates that signs of illness such as a fever, chills, or a sore throat are reasons to consult a healthcare professional.

Q: Does Imurel (Azathioprine) interact with warfarin or other blood thinners?

A: Regulatory information reports that Azathioprine may interact with certain anticoagulants (blood thinners) by potentially decreasing their effect. Although specific agents may vary, this interaction may necessitate the careful monitoring of blood clotting time.

Q: Is Imurel (Azathioprine) ever used for lupus?

A: Yes, regulatory-aligned dosage guides and clinical information note that Azathioprine is utilized for the management of Systemic Lupus Erythematosus (SLE), particularly when the disease affects the kidneys (lupus nephritis).

Q: Can Imurel (Azathioprine) cause hair loss?

A: Hair loss (alopecia) is explicitly listed among the adverse effects that have been reported in patients taking Azathioprine.

Advertisements

How should Imurel (Azathioprine) be stored and disposed of?

Storage and Disposal of Azathioprine Tablets

Azathioprine tablets must be stored at Controlled Room Temperature (20 C to 25 C, or 68 F to 77 F), with permitted excursions to 30 C. It is mandatory to protect the tablets from light and moisture, and they must not be frozen. For stability, the medication must be kept in a tightly closed container.


Safety and Waste Requirements

Consistent with official labeling, Azathioprine must be stored out of the sight and reach of children.

Disposal of any unused or expired product must be carried out according to local regulations for pharmaceutical waste, reflecting its classification as a potent antimetabolite. Utilize drug take-back programs whenever they are available.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Imurel (Azathioprine) found in:

A-Z Index: